Maurizio Pompili

Plain English
This study looked at how certain genetic differences might be linked to treatment-resistant schizophrenia (TRS) in patients. Researchers analyzed data from 221 people with difficult-to-treat mental disorders and found that specific gene variants, especially in the HTR2A gene, were more common in TRS patients than in healthy people. For example, the HTR2A rs6314 A|G and rs7997012 G|G genotypes were significantly more prevalent among TRS patients. Understanding these genetic links is important because it could help develop better treatments tailored to these patients' needs. Who this helps: This research benefits patients with treatment-resistant schizophrenia and their doctors.

Plain English
This study looked at how effective a medication called lumateperone is for treating depression in people with bipolar disorder. The analysis found that patients taking lumateperone had significantly lower depression scores than those taking a placebo, with marked improvements in their overall condition. This is important because it shows that lumateperone can be a strong treatment option for managing bipolar depression. Who this helps: Patients with bipolar disorder struggling with depressive episodes.

Plain English
This study looked at how cariprazine, an antipsychotic medication used for mood disorders, affects metabolic health, including weight, cholesterol, and blood sugar levels. The analysis included data from 19 studies and found that while patients experienced some weight gain on cariprazine—around 0.8 kg with a dose of 1.5 mg and about 1.5 kg with 3 mg—these changes were not significant enough to cause major health concerns. Importantly, there were no major impacts on blood sugar or cholesterol levels compared to a placebo, suggesting that cariprazine is safer for metabolic health than other similar medications. Who this helps: This benefits patients with affective disorders and their doctors by providing insights into the metabolic effects of cariprazine.

Plain English
This study examined how two different parts of the brain—dorsal and ventral hippocampus—work together when learning and expressing fear in male rats. Researchers found that while the ventral hippocampus was more active during the initial learning of fear, the dorsal hippocampus played a bigger role in expressing that fear, showing that both areas work together in a coordinated way. This finding changes the way we think about fear processing in the brain, highlighting a connection between learning and reacting to fear that could help us understand anxiety disorders better. Who this helps: This helps researchers and clinicians working with patients who have anxiety and fear-related disorders.

Plain English
This study looked at the impact of childhood mistreatment on the risk of suicide among migrant patients in psychiatric care, specifically how depression plays a role in this relationship. Researchers found that over one-third of the 102 participants had thoughts of suicide, with higher rates of suicidal thoughts among Asian migrants compared to Europeans. The study revealed that emotional abuse completely linked to suicidal thoughts through depression, while physical and sexual abuse had a partial connection. This research highlights the importance of providing sensitive mental health support that considers both past trauma and the unique challenges faced by migrants. Who this helps: This helps patients with a history of childhood abuse and migration challenges.

Plain English
This study looked at how a family history of mood disorders, combined with the amount of sunlight in different locations, affects patients with bipolar I disorder. Researchers analyzed data from 5,842 patients worldwide and found that those living closer to the poles were more likely to have a family history of mood disorders, with a significant increase in risk for women. This is important because it highlights that both genetics and environmental factors, like sunlight exposure, can influence mental health risks, especially for families of women with bipolar disorder. Who this helps: This helps patients and their families understand how location and family history may impact their mental health risks.

Plain English
This research looked at the antidepressant trazodone, which is not only approved for major depressive disorder (MDD) but also shows promise for conditions like insomnia and anxiety. The study found that at lower doses (25-75 mg) trazodone can help with sleep and anxiety, while higher doses (150-300 mg) provide full antidepressant effects. Its various forms and minimal side effects, such as a low risk of sexual dysfunction, make it a flexible option for treating multiple issues, especially for patients with complex health needs. Who this helps: Patients dealing with depression, anxiety, insomnia, and other related disorders.

Plain English
This study looked at a tool called the Multisource Comorbidity Score (MCS) to see how well it works for predicting health outcomes in older residents of Barcelona, Spain. Researchers followed nearly 200,000 people aged 50 and over from 2016 to 2019 and found that the MCS, especially the enhanced version that included more local health data, was effective at predicting 1-year mortality, with scores showing a sharp increase in predictive ability (0.742 for the original, up to 0.771 for the enhanced version). This matters because it helps healthcare providers better understand and manage the health complexities of older adults, potentially improving patient outcomes and healthcare planning. Who this helps: This benefits doctors and healthcare providers working with older patients.

Plain English
This study looked at burnout levels in psychiatry residents compared to other medical residents and explored what factors influenced these burnout scores. It involved over 1,800 medical residents and found that those with better emotional regulation and interpersonal skills experienced lower levels of burnout. Specifically, residents who participated in regular supervision sessions reported less burnout, suggesting that mentalizing skills and support can help manage stress during training. Who this helps: This benefits psychiatry residents, program directors, and training institutions looking to improve resident well-being.

Plain English
This study examined how cariprazine, a medication used to treat schizophrenia, affects weight, cholesterol, and blood sugar levels. Researchers found that patients taking cariprazine experienced a slight weight gain, but their cholesterol and glucose levels did not change significantly compared to those on a placebo. This is important because it suggests that cariprazine may have fewer negative effects on metabolic health than some other antipsychotic medications. Who this helps: This information benefits patients with schizophrenia who are concerned about weight gain and metabolic issues related to their treatment.

Plain English
This study looked at how effective different doses of vitamin B12 injections (cyanocobalamin) are for patients with a specific type of stomach condition (corpus atrophic gastritis) that causes vitamin B deficiency. Out of 213 patients, nearly 69% responded well to the lower treatment dose of 20,000 micrograms per year, while the remaining 31% needed a higher dose of 30,000 micrograms per year to restore their vitamin B levels. This matters because vitamin B deficiency can lead to serious health issues like anemia and neurological problems, so finding the right treatment is crucial. Who this helps: This research benefits patients with corpus atrophic gastritis and vitamin B deficiency, especially those requiring vitamin B supplementation.

Plain English
This study explored the experiences of people who have attempted suicide, gathering insights from both individuals with lived experience and academic researchers. It revealed that these individuals often feel overwhelmed by hopelessness and despair, face stigma, and encounter barriers to accessing mental health care. Understanding their complex experiences is crucial for improving support and care, as it emphasizes the need for sensitivity and accessibility in mental health services. Who this helps: This helps patients dealing with suicidal thoughts and their healthcare providers.

Plain English
This study looked at vortioxetine, a medication used to treat major depressive disorder, to see how effective it is in reducing symptoms of depression in the short term. The researchers found that both 10 mg and 20 mg doses of vortioxetine significantly improved depression, anxiety symptoms, and cognitive function, with higher effectiveness at the 20 mg dose. Vortioxetine was also well-tolerated, with few serious side effects, making it a strong option for treating acute depression. Who this helps: This helps patients with major depressive disorder and their doctors in choosing effective treatments.

Plain English
This study focused on understanding the thoughts and feelings that lead to suicidal crises in psychiatric patients. Researchers developed a new questionnaire called the Suicidal Crisis Evaluation Scale (SCES) and found that patients who had recently attempted suicide scored significantly higher on this scale. Specifically, around 70% of the results could be explained by a common psychological factor, and current depression was linked to negative mental states, helping to connect different emotional traits with suicidal thoughts. Who this helps: This information benefits patients by improving how doctors assess and understand suicide risk.

Plain English
This study looked at whether combining the medications dextromethorphan and bupropion could help reduce mental pain in people suffering from major depressive disorder (MDD). Researchers believe that addressing mental pain is important because it can be linked to a higher risk of suicide. They proposed that this combination might be effective because it targets the opioid system in the brain, offering a new approach for treating depression. Who this helps: This benefits patients dealing with major depressive disorder.

Plain English
This study looked at how childhood trauma, feelings of hopelessness, symptoms of depression, and mental pain interact in people with severe mental disorders. Researchers analyzed data from 2,147 participants and found that mental pain is a key factor that connects these different experiences, suggesting it plays a critical role in mental health. Addressing mental pain is essential for better treatment and understanding of these individuals, regardless of their specific diagnosis. Who this helps: This helps patients dealing with severe mental disorders and the doctors treating them.

Plain English
This study focused on tardive dyskinesia (TD), a movement disorder often caused by long-term use of certain psychiatric medications, especially older antipsychotics. The research found that while newer medications lower the risk, TD still affects many patients, particularly older adults, and early diagnosis is crucial for effective treatment. Treatments like VMAT2 inhibitors can significantly help manage symptoms, but there’s a need for tailored approaches and better monitoring to improve patient outcomes. Who this helps: This research benefits patients with tardive dyskinesia and their doctors by providing better management options and guiding treatment strategies.

Plain English
This research examined suicide rates among older adults (75 and over) in 48 countries from 1990 to 2022 to understand the patterns and trends. It found that men are 3 to 7 times more likely to die by suicide than women, with the highest male suicide rate at 50.9 deaths per 100,000 people in Central-Eastern Europe and the lowest at 12.8 in Northern Europe. Understanding these rates is crucial because it highlights significant variations in suicide trends across countries, which can help in creating targeted interventions to reduce these preventable deaths. Who this helps: This helps public health officials and policymakers in developing better support and prevention strategies for older adults.

Plain English
This study focused on the use of lithium as the best treatment for people with bipolar disorder, gathering expert opinions from 100 psychiatrists in Italy. The researchers found strong agreement among experts that lithium should be the first choice for treating bipolar disorder and preventing episodes of mania and depression. Despite its proven effectiveness, prescription rates for lithium have been declining, highlighting a gap between clinical guidelines and actual practice that needs to be addressed. Who this helps: Patients with bipolar disorder.

Plain English
This study explored how health professionals view the support needs of older people with intellectual disabilities in Italy. Researchers surveyed 113 workers in residential-care organizations, focusing on eight areas that contribute to quality of life. They found that emotional and physical well-being were the most important support needs, while personal development and social inclusion were seen as less critical. Who this helps: This information benefits caregivers and health professionals working with older individuals with intellectual disabilities.

Plain English
This study looked at how well intranasal esketamine works for people with depression that hasn't improved with other treatments. Researchers followed 21 patients over six months and found that their symptoms of depression significantly dropped: scores showed improvement at both three and six months. There was also a notable decrease in feelings of hopelessness and thoughts of suicide during this time. Who this helps: This benefits patients with treatment-resistant depression and their healthcare providers.

Plain English
This study looked at the risk of suicide among 101 female patients with eating disorders, noting that they are at a higher risk than the general population. It found that suicidal thoughts in the past month were closely linked to experiences of childhood sexual abuse, feelings of hopelessness, and a loss of meaning in life. Understanding these factors can help improve suicide prevention strategies for these patients. Who this helps: This helps patients with eating disorders and healthcare providers working with them.

Plain English
This paper examines the issue of suicide, highlighting the importance of understanding its complexities to improve prevention methods. It discusses insights from eight experts and emphasizes the need for tailored approaches to better address the unique needs of different individuals at risk. The study promotes the use of both medication and therapy to effectively reduce suicide risk and improve patients' lives, which ultimately benefits families and communities. Who this helps: This helps patients at risk of suicide and mental health professionals working to prevent it.

Plain English
This study looked at the link between jobs and suicide rates in Italy from 2005 to 2018. It found that unemployed individuals were twice as likely to die by suicide compared to those with jobs. Specific high-risk groups included men in security and investigation and women in healthcare and social care. The research highlights the importance of understanding how work conditions can affect mental health and suicide risk. Who this helps: This information helps policymakers and mental health professionals support at-risk workers.

Plain English
This research paper looked at the risks of switching from depression to mania in people with bipolar disorder who take antidepressants. Out of 1,362 patients studied, it found no antidepressant had a significantly higher risk of causing mania compared to a placebo. However, venlafaxine had the highest estimated risk of 4.53, but this wasn't considered statistically significant, indicating the need for caution when using it. Who this helps: Patients with bipolar disorder and their doctors.

Plain English
This study focused on creating a method to identify new cases of breast cancer in the Marche Region of Italy from 2010 to 2021 using health databases. Researchers successfully identified 18,158 new breast cancer cases and found that the average incidence rate was 224.7 cases per 100,000 people. The study highlighted a drop in breast cancer cases during 2020-2021, likely due to the impact of the COVID-19 pandemic, and emphasized the importance of these health databases for tracking cancer trends when standard registry data might be slow. Who this helps: Patients and public health officials benefit from more accurate and timely cancer tracking.

Plain English
This study looked at how variations in a specific gene, called HTR2A, might be linked to obsessive-compulsive disorder (OCD) that doesn't respond to treatment, comparing it with other difficult-to-treat mental health conditions. Researchers analyzed data from 210 people, finding that a specific genetic variation (rs7997012) was strongly associated with a higher chance of having treatment-resistant OCD—specifically, those with the A|A genotype were nearly 7 times more likely to be in this group compared to those with other genotypes. Understanding these genetic links can help develop more tailored treatments for OCD, making it easier for doctors to identify and treat patients effectively. Who this helps: This research benefits patients with obsessive-compulsive disorder and their healthcare providers.

Plain English
This study looked at how a specific part of the brain, the ventral hippocampus, influences the control of fear memories in a specific context after those fears have been reduced. Researchers found that stimulating connections from the ventral hippocampus to another brain area significantly reduced fear responses in rats when they were exposed to a familiar environment that normally triggers fear. This is important because it helps clarify how brain circuits manage fear, which could lead to better treatments for anxiety disorders. Who this helps: This research benefits patients with anxiety disorders by potentially guiding improved therapeutic strategies.

Plain English
This study looked at how common dementia and parkinsonism are in the Marche region of Italy, using healthcare records from 2016 to 2021. Researchers found that in 2021, dementia affected about 31.2 out of every 100 people aged 40 and older, while parkinsonism affected about 7.1 per 100. Knowing these numbers is important for planning healthcare resources and services for older adults, especially since the prevalence is higher for both conditions in older age groups. Who this helps: This benefits patients and healthcare planners focusing on aging populations.

Plain English
This study looked at suicide trends in Europe from 1990 to 2022, focusing on how rates changed based on age and sex. It found that older individuals (85+) had the highest suicide rates, with France at 82 per 100,000. However, there was a troubling increase in youth suicide rates, particularly among girls aged 15 to 19 in Western (up 12%), Southern (up 24.5%), and Northern Europe (up 44%). Understanding these patterns is crucial for creating targeted prevention strategies that can effectively address the specific needs of different age groups. Who this helps: This helps patients, especially young people and older adults, as well as healthcare providers working on prevention strategies.

Plain English
This study looked at how groups of brain cells, called cell assemblies, communicate with special neurons that help interpret their activity. Researchers found that these "reader" neurons can respond collectively and flexibly to information from cell assemblies, showing that they adapt based on learning and experiences. This matters because it highlights a key way the brain organizes and processes information, which can improve our understanding of memory and decision-making. Who this helps: This benefits researchers, patients with memory issues, and those interested in brain health.

Plain English
This study examined how mental pain, or "psychache," affects the likelihood of suicide attempts in patients with psychiatric disorders. Of 179 patients monitored for one year, 26 attempted suicide, with 24 of those attempts happening within the first six months. The research found that higher mental pain scores increased the odds of a suicide attempt by 3.8% for each additional point on the scale, suggesting that tools measuring mental pain can help identify individuals at risk for suicide. Who this helps: This helps patients with psychiatric disorders and their doctors in better recognizing and addressing suicide risk.

Plain English
This study looked at how adding lithium to the treatment of patients with bipolar disorder (BD) and major depressive disorder (MDD) for one year affected the chances of new episodes of illness and suicidal thoughts or attempts compared to a year of treatment without lithium. The results showed that lithium treatment significantly lowered the risk of new episodes by over three times, reduced suicidal thoughts by nearly five times, and decreased suicide attempts by more than six times. This matters because it highlights lithium’s powerful role in improving mental health outcomes for these patients. Who this helps: This benefits patients with bipolar disorder and major depressive disorder.

Plain English
This study looked at how well a common blood test, alanine aminotransferase (ALT), helps diagnose and manage chronic liver diseases like fatty liver disease and chronic hepatitis. Researchers found that while ALT is still important, its effectiveness varies based on factors like age and gender, and suggested adjusting the normal ranges for ALT levels to improve its use in detecting liver issues. This matters because refining ALT testing could lead to earlier diagnosis and better treatment for liver diseases, especially in people who don't show obvious symptoms. Who this helps: Patients with chronic liver diseases and healthcare providers.

Plain English
This study reviewed 105 cases of GAPO syndrome, a rare genetic disorder that affects growth, skin, teeth, and vision. The researchers found that this condition has multiple symptoms mainly involving bones, skin, and eyes and is caused by specific genetic changes. Understanding GAPO syndrome's characteristics is crucial because it can lead to better early diagnosis and treatment strategies. Who this helps: This helps patients with GAPO syndrome and their healthcare providers.

Plain English
Researchers studied how a special imaging technique called N-ammonia PET-CT can help evaluate how well treatment is working for patients with advanced liver cancer (HCC) who are receiving antiangiogenic therapy. Out of 18 patients followed after treatment, 72% showed some response, but 83% experienced disease progression within about 14 months, and nearly 78% died during that time. The study found that certain imaging results could help predict early disease progression and survival, which is important for planning future patient care. Who this helps: This helps patients with advanced liver cancer and their doctors understand treatment effectiveness and prognosis.

Plain English
This study looked at how well a combination treatment of atezolizumab and bevacizumab works for patients with advanced liver cancer, specifically focusing on those with liver function problems. It involved 247 patients and found that the average survival time was about 18 months, with those in better liver health (Child Pugh A) living longer (over 20 months) than those with worse liver function (Child Pugh B, around 10 months). Interestingly, about 26% of patients experienced worsening liver function, but many were able to continue the treatment afterward and had similar survival rates to those who never had liver issues, which shows the treatment's adaptability and the importance of proper management for these patients. Who this helps: This benefits liver cancer patients and their healthcare providers.

Plain English
This study looked at the growth patterns of focal nodular hyperplasia (FNH), a type of non-cancerous liver lesion, by following 55 patients with ultrasound scans over an average of nearly five years. Researchers found that most lesions either stayed the same size (48%) or got smaller (35%), with only a small percentage increasing in size (7%). This matters because it shows that FNH lesions are often stable or shrink over time, providing reassurance to patients and doctors about the natural course of these lesions. Who this helps: Patients with focal nodular hyperplasia and their doctors.

Plain English
This study examined how well multiparametric ultrasound can predict whether esophageal varices, which are swollen veins in the esophagus, can be successfully treated with a procedure called endoscopic variceal band ligation (EVBL) in patients with liver cirrhosis. Out of 41 patients, 28 (68.3%) had successful treatment after one month, while 13 (31.7%) needed another procedure. The findings showed that changes in liver and spleen stiffness measurements, along with ultrasound imaging, could help predict treatment outcomes, reducing the need for follow-up endoscopy. Who this helps: This helps patients with cirrhosis by providing a non-invasive way to predict treatment success.

Plain English
This study looked at the CAR-OLT score, a tool designed to predict heart problems for patients who need a liver transplant. Among 342 patients evaluated, the CAR-OLT score was able to identify candidates at low risk for heart issues, allowing 25% of them to avoid expensive cardiac stress tests, saving around €574.70 per patient. This is important because it can streamline the evaluation process for liver transplant candidates and reduce unnecessary medical costs. Who this helps: Patients needing liver transplants and healthcare systems.

Plain English
This study looked at different ultrasound methods to assess liver conditions in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), a condition that can lead to more severe liver problems. Researchers found that certain ultrasound techniques, like transient elastography and two-dimensional shear-wave elastography, accurately diagnosed advanced liver fibrosis with very high success rates (93% and 90%, respectively). By using a new scoring system that combines viscosity and other test results, they could better identify patients at risk of severe liver inflammation, potentially sparing low-risk patients from unnecessary biopsies. Who this helps: This benefits patients with liver disease by offering safer ways to assess their condition without invasive procedures.

Plain English
This study looked at how well obeticholic acid (OCA) works and its safety over the long term for patients with primary biliary cholangitis (PBC). Researchers followed 747 patients for about 2 years and found that the drug improved liver function in 57% of patients while 17% stopped taking the medication mainly due to itching. The research is important because it shows that OCA can help manage PBC effectively over time, especially for patients who respond well to the treatment. Who this helps: This benefits patients with PBC and their doctors.

Plain English
This study looked at the differences between men and women who have hepatitis delta virus (HDV) infections, which can cause severe liver issues. Researchers analyzed data from 513 patients and found that 73.4% of men and 77.8% of women had cirrhosis, a serious liver condition. However, younger women, especially those from non-Italian backgrounds, were more likely to develop cirrhosis compared to younger men; 80.9% of younger females had cirrhosis, compared to only 16.1% of younger males. Who this helps: This research benefits doctors and healthcare providers by providing insights for better treatment for both men and women with HDV.

Plain English
This study looked at how well a technique called shear wave elastography (SWE) works to measure stiffness in the liver, spleen, and pancreas of 50 healthy adults. The researchers found that measuring stiffness in the liver and spleen was very reliable, with liver stiffness averaging about 4.3 kPa and spleen stiffness about 21.1 kPa, but measuring stiffness in the pancreas was not as dependable, showing more variation (5.2 to 7.6 kPa). Knowing these differences is important because it helps doctors understand which organ stiffness measurements they can trust and which they can't when assessing health issues. Who this helps: This helps doctors in correctly interpreting organ stiffness measurements for better patient care.

Plain English
This study looked at the presence of histones, which are proteins found in the blood, to see if they could help identify patients with a type of liver disease called MASLD and its more severe form, MASH, who are at risk of developing liver cancer (HCC). The researchers found that patients with MASLD and MASH had higher levels of certain histones compared to healthy individuals, while specific histones were lower in MASH compared to non-MASH cases. These findings matter because they could lead to new and quicker ways to identify patients at risk of progressing to liver cancer. Who this helps: This research benefits patients with liver disease and their doctors by providing new tools for monitoring disease progression.

Plain English
This study looked at how different ways people connect with others (attachment styles) and their social needs might relate to thoughts about suicide in patients with mental health disorders. It involved 181 patients and found that feeling a burden to others was linked to increased suicidal thoughts, especially in those who didn't feel secure in their relationships. This matters because understanding these links can help create better support and treatment plans to prevent suicide. Who this helps: This helps patients struggling with suicidal thoughts and their mental health professionals.